首页|期刊导航|医学分子生物学杂志|Plk1在神经退行性疾病中的研究进展

Plk1在神经退行性疾病中的研究进展OA

Research Progress on Plk1 in Neurodegenerative Diseases

中文摘要英文摘要

Polo样激酶1(Polo-like kinase 1,Plk1)作为丝氨酸/苏氨酸蛋白激酶家族的重要成员,是细胞周期调控的核心调控因子,其功能失调与肿瘤发生密切相关.近年来研究发现,Plk1在终末分化的神经元中异常表达,并与阿尔茨海默病、帕金森病、肌萎缩侧索硬化症等神经退行性疾病的病理过程密切相关.尤其值得注意的是,Plk1在阿尔茨海默病、帕金森病等疾病中扮演着双重角色:它不仅通过驱动异常细胞周期重启直接介导神经元死亡,同时也参与调控自噬等神经保护过程.Plk1在神经退行性疾病中的复杂功能,特别是其看似矛盾的双重作用,为理解神经退行性病变机制及开发新的治疗策略提供了全新视角.

As a key member of the serine/threonine protein kinase family,Polo-like kinase 1(Plk1)is a core regulator of the cell cycle,whose dysfunction is closely related to tumorigene-sis.Recent research has found that Plk1 is abnormally expressed in terminally differentiated neurons and is closely associated with the pathological processes of neurodegenerative diseases such as Alzhe-imer's disease,Parkinson's disease and amyotrophic lateral sclerosis.It is particularly noteworthy that Plk1 plays a dual role in diseases like Alzheimer's:it not only directly mediates neuronal death by driving aberrant cell cycle re-entry but also participates in regulating neuroprotective processes such as autophagy.The complex role of Plk1 in neurodegenerative diseases,particularly its seeming-ly contradictory dual function,offers a new perspective for understanding the mechanisms underlying neurodegenerative disorders and developing novel therapeutic strategies.

陈雨柔;于楠;李伟

火箭军特色医学中心疾病预防控制科 北京市,100088火箭军特色医学中心疾病预防控制科 北京市,100088火箭军特色医学中心疾病预防控制科 北京市,100088

生物科学

Plk1神经退行性疾病阿尔茨海默病帕金森病肌萎缩侧索硬化症

Polo-like kinase 1neurodegenerative diseasesAlzheimer's diseaseParkin-son's diseaseamyotrophic lateral sclerosis

《医学分子生物学杂志》 2026 (4)

466-470,5

国家自然科学基金(No.81602796) This work was supported by a grant from the National Natural Science Foundation of China(No.81602796).

10.3870/j.issn.1672-8009.2026.04.014

评论